Skip to main content
SpringerLink
Log in

Zellstoffwechsel des Alveolarepithels Typ II: Bedeutung bei der Therapie des ARDS

  • Conference paper
Metabolismus

Part of the book series: Intensivmedizinisches Seminar ((INTENSIVM.SEM.,volume 7))

  • 39 Accesses

Zusammenfassung

Das ARDS („adult respiratory distress syndrome“) wurde erstmals 1967 von Ashbaugh und Mitarbeitern [1]. beschrieben. Trotz der vielschichtigen Ursachen wie u. a. Sepsis, Schock, Pneumonie, Trauma und Aspiration ist das ARDS unabhängig von der Ätiologie gekennzeichnet durch a) eine ausgeprägte, Sauerstoff-refraktäre arterielle Hypoxämie, b) einen erhöhten intrapulmonalen Shunt, c) eine verminderte Lungencompliance und d) ein reduziertes Lungenvolumen bei fehlendem Hinweis auf linksventrikuläres Versagen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Absaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet ii: 319–323

    Google Scholar 

  2. Seeger W, Günther A, Walmrath HD, Grimminger F, Lasch HG (1993) Alveolar surfactant and adult respiratory distress syndrome. Clin Invest 71: 177–190

    Article  CAS  Google Scholar 

  3. Spragg RG, Gilliard N, Richman P, Smith RM, Hite D, Pappert D, Heldt GP, Meritt TA (1992) The adult respiratory distress syndrome: clinical aspects relevant to surfactant supplementation. In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant: from molecular biology to clinical practice. Elsevier Science Publishers, pp 685–703

    Google Scholar 

  4. Hamm H, Fabel H, Bartsch W (1992) The surfactant system of the adult lung: physiology and clinical perspectives. Clin Invest 70: 637–657

    Article  CAS  Google Scholar 

  5. Hawgood S, Shiffer K (1991) Structure and properties of the surfactant-associated proteins. Ann Rev Physiol 53: 375–394

    Article  CAS  Google Scholar 

  6. Dobbs LG, Wright JR, Gonzales R, Venstrom K, Nellenbogen J (1987) Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alevolar type II cells. Proc Natl Acad Sci 84: 1010–1014

    Article  PubMed  CAS  Google Scholar 

  7. Tsuzuki A, Kuroki Y, Akino T (1993) Pulmonary surfactant protein A-meditated uptake of phosphatidylcholine by alveolar type II cells. Am Physiol 265 (Lung Cell Mol Physiol 9): L193 - L199

    CAS  Google Scholar 

  8. Wright JR, Wager RE, Hawgood S, Dobbs LG, Clements JA (1987) Surfactant apoprotein Mr = 26.000–36.000 enhances uptake of liposomes by type II cells. J Biol Chem 262: 2888–2894

    PubMed  CAS  Google Scholar 

  9. Petty TL, Silvers WG, Paul GW, Stanford RE (1979) Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75: 571–574

    Article  PubMed  CAS  Google Scholar 

  10. Hallman M, Spragg RG, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormality in respiratory failure, study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 70: 673–683

    Article  PubMed  CAS  Google Scholar 

  11. Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruch J, SchmidtNeuerburg KP (1990) Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 30: 19–26

    Article  PubMed  CAS  Google Scholar 

  12. Pison RL, Obertacke U, Seeger W, Hawgood S (1992) Surfactant protein A ( SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 22: 712–718

    Article  PubMed  CAS  Google Scholar 

  13. Greogry TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler III AA, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976–1981

    Article  Google Scholar 

  14. Spragg RG, Richman P, Gilliard N, Merritt TA (1987) The future for surfactant therapy of the adult respiratory distress syndrome. In: Lachmann B (ed) Surfactant replacement therapy. Springer, New York, pp 203–211

    Google Scholar 

  15. Li JJ, Sanders RL, McAdam KP, Hales CA, Thompson BT, Gelfand JA, Burke JF (1989) Impact of C-reactive protein ( CRP) on surfactant function. J Trauma 29: 1690–1697

    Article  PubMed  CAS  Google Scholar 

  16. Holm BA, Matalon S, Finkelstein JN, Notter RH (1988) Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 65: 2672–2678

    PubMed  CAS  Google Scholar 

  17. Edelson JD, Vadas P, Villar J, Mullen JBM, Pruzanski W (1991) Acute lung injury induced by phospholipase A2. Am Rev Resp Dis 143: 1102–1109

    PubMed  CAS  Google Scholar 

  18. Oldham KT, Guice KS, Stetson PS, Wolfe RR (1989) Bacteremia-induced suppression of alveolar surfactant production. J Surg Res 47: 397–402

    Article  PubMed  CAS  Google Scholar 

  19. Lachmann B (1987) Surfactant replacement in acute respiratory failure: animal studies and first clinical trials. In: Lachmann B (ed) Surfactant replacement therapy. Springer, New York, pp 212–223

    Google Scholar 

  20. Nosaka S, Sakai T, Yonekura M, Yoshikawa K (1990) Surfactant for adults with respiratory failure. Lancet 336: 947–948

    Article  PubMed  CAS  Google Scholar 

  21. Subbig K, Schmidt H, Böhrer H, Huster Th, Bach A, Motsch J (1992) Surfactantapplikation bei akutem Lungenversagen. Anaesthesist 41: 555–558

    Google Scholar 

  22. Lewis J, Tabor B, Ikegami M, Jobe A (1991) Physiological response to aerosolized surfactant in lung-lavaged sheep. Am Rev Resp Dis 143: A769

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Anästhesie und Allgemeine Intensivmedizin, Universität Innsbruck, Anichstraße 35, A-6020, Innsbruck, Österreich

    Dr. W. Schobersberger

  2. Klinik für Anästhesie und Allgemeine Intensivmedizin, Universität Innsbruck, Österreich

    F. Friedrich & G. Putz

Authors
  1. Dr. W. Schobersberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Friedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Putz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Steyr, Österreich

    Gunther Kleinberger

  2. Wien, Österreich

    Kurt Lenz , Bruno Schneeweiß  & Werner Waldhäusl ,  & 

  3. Basel, Schweiz

    Rudolf Ritz

  4. Hildesheim, Deutschland

    Hans-Peter Schuster

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag/Wien

About this paper

Cite this paper

Schobersberger, W., Friedrich, F., Putz, G. (1994). Zellstoffwechsel des Alveolarepithels Typ II: Bedeutung bei der Therapie des ARDS. In: Kleinberger, G., Lenz, K., Ritz, R., Schneeweiß, B., Schuster, HP., Waldhäusl, W. (eds) Metabolismus. Intensivmedizinisches Seminar, vol 7. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9342-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9342-6_12

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82538-9

  • Online ISBN: 978-3-7091-9342-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation